Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT OF RBSM, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Icagen, Inc. | f10k2017ex23-1_icageninc.htm |
| EX-32.1 - CERTIFICATION - Icagen, Inc. | f10k2017ex32-1_icageninc.htm |
| EX-31.2 - CERTIFICATION - Icagen, Inc. | f10k2017ex31-2_icageninc.htm |
| EX-31.1 - CERTIFICATION - Icagen, Inc. | f10k2017ex31-1_icageninc.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - Icagen, Inc. | f10k2017ex21-1_icageninc.htm |
| EX-4.19 - FORM OF AMENDED AND RESTATED WARRANT DATED MAY 15, 2017 ISSUED BY ICAGEN, INC. - Icagen, Inc. | f10k2017ex4-19_icageninc.htm |
| 10-K - ANNUAL REPORT - Icagen, Inc. | f10k2017_icageninc.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Icagen, Inc., a Delaware corporation (the “Company”), on Form 10-K for the period ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Korb, Chief Financial Officer of the Company, certify, pursuant to Section 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) and 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| April 17, 2018 | /s/ Mark Korb |
Chief Financial Officer | |
| (Principal Financial Officer) |